These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
530 related articles for article (PubMed ID: 28272106)
1. M1 and M2 macrophages' clinicopathological significance in cutaneous melanoma. Falleni M; Savi F; Tosi D; Agape E; Cerri A; Moneghini L; Bulfamante GP Melanoma Res; 2017 Jun; 27(3):200-210. PubMed ID: 28272106 [TBL] [Abstract][Full Text] [Related]
2. The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma. Salmi S; Siiskonen H; Sironen R; Tyynelä-Korhonen K; Hirschovits-Gerz B; Valkonen M; Auvinen P; Pasonen-Seppänen S Melanoma Res; 2019 Jun; 29(3):237-247. PubMed ID: 30399061 [TBL] [Abstract][Full Text] [Related]
3. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer. Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry. Rakaee M; Busund LR; Jamaly S; Paulsen EE; Richardsen E; Andersen S; Al-Saad S; Bremnes RM; Donnem T; Kilvaer TK Neoplasia; 2019 Mar; 21(3):282-293. PubMed ID: 30743162 [TBL] [Abstract][Full Text] [Related]
5. Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination. Yamaguchi T; Fushida S; Yamamoto Y; Tsukada T; Kinoshita J; Oyama K; Miyashita T; Tajima H; Ninomiya I; Munesue S; Harashima A; Harada S; Yamamoto H; Ohta T Gastric Cancer; 2016 Oct; 19(4):1052-1065. PubMed ID: 26621525 [TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of CD204-positive macrophages in lung squamous cell carcinoma: possible contribution of Cd204-positive macrophages to the tumor-promoting microenvironment. Hirayama S; Ishii G; Nagai K; Ono S; Kojima M; Yamauchi C; Aokage K; Hishida T; Yoshida J; Suzuki K; Ochiai A J Thorac Oncol; 2012 Dec; 7(12):1790-1797. PubMed ID: 23154550 [TBL] [Abstract][Full Text] [Related]
7. Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors. Massi D; Marconi C; Franchi A; Bianchini F; Paglierani M; Ketabchi S; Miracco C; Santucci M; Calorini L Hum Pathol; 2007 Oct; 38(10):1516-25. PubMed ID: 17640716 [TBL] [Abstract][Full Text] [Related]
8. The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression. Lin CN; Wang CJ; Chao YJ; Lai MD; Shan YS BMC Cancer; 2015 Mar; 15():128. PubMed ID: 25872762 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis. Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008 [TBL] [Abstract][Full Text] [Related]
10. Role of tumor-associated macrophages at the invasive front in human colorectal cancer progression. Inagaki K; Kunisho S; Takigawa H; Yuge R; Oka S; Tanaka S; Shimamoto F; Chayama K; Kitadai Y Cancer Sci; 2021 Jul; 112(7):2692-2704. PubMed ID: 33964093 [TBL] [Abstract][Full Text] [Related]
11. CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients. Yang L; Wang F; Wang L; Huang L; Wang J; Zhang B; Zhang Y Oncotarget; 2015 Apr; 6(12):10592-603. PubMed ID: 25871392 [TBL] [Abstract][Full Text] [Related]
12. The clinicopathological impact of tumor-associated macrophages in patients with cutaneous malignant melanoma. Asai Y; Yanagawa N; Osakabe M; Yamada N; Sugimoto R; Sato A; Ito K; Koike Y; Tanji T; Sakuraba M; Sato T; Sugai T J Surg Oncol; 2024 Feb; 129(2):381-391. PubMed ID: 37916518 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of CD163 expression and its correlation with cyclooxygenase-2 and vascular endothelial growth factor expression in cutaneous melanoma. Lee WJ; Lee MH; Kim HT; Won CH; Lee MW; Choi JH; Chang SE Melanoma Res; 2019 Oct; 29(5):501-509. PubMed ID: 30575644 [TBL] [Abstract][Full Text] [Related]
14. The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. Ma J; Liu L; Che G; Yu N; Dai F; You Z BMC Cancer; 2010 Mar; 10():112. PubMed ID: 20338029 [TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages (TAMs): clinical-pathological parameters in squamous cell carcinomas of the lower lip. Lúcio PS; Ribeiro DC; Aguiar MC; Alves PM; Nonaka CF; Godoy GP Braz Oral Res; 2016 Aug; 30(1):e95. PubMed ID: 27556682 [TBL] [Abstract][Full Text] [Related]
16. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure. Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of diametrically polarized tumor-associated macrophages in renal cell carcinoma. Xu L; Zhu Y; Chen L; An H; Zhang W; Wang G; Lin Z; Xu J Ann Surg Oncol; 2014 Sep; 21(9):3142-50. PubMed ID: 24615178 [TBL] [Abstract][Full Text] [Related]
18. A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients. Zhang M; He Y; Sun X; Li Q; Wang W; Zhao A; Di W J Ovarian Res; 2014 Feb; 7():19. PubMed ID: 24507759 [TBL] [Abstract][Full Text] [Related]